OrbiMed’s Strongbridge Biopharma plc. SBBP Stock Holding History

OrbiMed’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-794,675	Closed	-$1.62M	–	185
2021 Q3	$1.62M	Sell	794,675 -949,994	-54%	-$2.21M	0.02%	165
2021 Q2	$5.18M	Hold	1,744,669	–	–	0.05%	146
2021 Q1	$4.82M	Sell	1,744,669 -1,744,700	-50%	-$5.26M	0.05%	145
2020 Q4	$8.48M	Hold	3,489,369	–	–	0.07%	126
2020 Q3	$7.33M	Buy	+3,489,369	New	+$11.8M	0.09%	118

OrbiMed's SBBP Position: Q4 2021 in Review

OrbiMed sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 794,675 shares — an estimated $1.62M sold.

OrbiMed first reported a position in SBBP in Q3 2020 and held it in 5 quarters. The position peaked at $8.48M in Q4 2020. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

OrbiMed reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
OrbiMed sold 794,675 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $1.62M.
OrbiMed first reported a position in Strongbridge Biopharma plc. in Q3 2020 and held it in 5 quarters.
OrbiMed's Strongbridge Biopharma plc. position peaked at $8.48M in Q4 2020.
0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on OrbiMed's 13F filing for Q4 2021, filed 14 Feb 2022.